Department of Health Policy and Management, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, 1104G McGavran-Greenberg Hall, CB#7411, Chapel Hill, NC 27599-7411, USA.
Psychiatr Serv. 2010 Feb;61(2):118-20. doi: 10.1176/ps.2010.61.2.118.
This study examined medication use among Medicare beneficiaries and dually eligible beneficiaries before and after the implementation of Medicare Part D on January 1, 2006. Nationally representative 2004-2006 data from the Medical Expenditure Panel Survey were used. Two large classes of psychotropic medications (antidepressant and antipsychotic medications) and two large classes of nonpsychotropic medications (lipid-lowering and antihypertensive agents) were examined to determine whether changes in prescription patterns occurred as a result of the implementation of Part D. There was no strong evidence that Part D was associated with large changes in access to medications in the four classes of medications examined here.
本研究考察了 2006 年 1 月 1 日 Medicare 部分 D 实施前后 Medicare 受益人和双重资格受益人的药物使用情况。使用了来自医疗支出面板调查的具有全国代表性的 2004-2006 年数据。检查了两类大的精神药物(抗抑郁药和抗精神病药物)和两类大的非精神药物(降血脂药和抗高血压药物),以确定实施部分 D 是否导致处方模式发生变化。没有强有力的证据表明部分 D 与这里检查的四类药物的药物获取有很大变化有关。